General MedicationsDELAYED RELEASEGeneric

POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL

Standard Dose

2MG; 5MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL is listed in Drugs@FDA under application 090197 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL Form and strength SOLUTION; ORAL AND TABLET; DELAYED RELEASE - 2MG; 5MG Sponsor NOVEL LABS INC Submission history Latest submission status date: 2010-05-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL is listed in Drugs@FDA under application 090197 (ANDA). Marketing status: None (Tentative Approval) Active ingredient POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL Form and strength SOLUTION; ORAL AND TABLET; DELAYED RELEASE - 2MG; 5MG Sponsor NOVEL LABS INC Submission history Latest submission status date: 2010-05-27 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.